title: The management of fatigue in cancer patients.
abstract: Severe, debilitating fatigue is common in cancer patients. For many, it is the symptom that interferes most with normal routines. Virtually every modality used to treat cancer may cause fatigue, as can complications of the disease such as sleep disturbances, infections, malnutrition, hypothyroidism, and anemia. There is a significant overlap between depression and fatigue in many patients. Given the high prevalence of cancer-related fatigue, frequent assessment of patients is essential. The evaluation should include an attempt to identify reversible causes of fatigue, and screening for depression. However, many cancer patients suffer from fatigue even in the absence of any identifiable, reversible cause. For these patients, consideration can be given to suitable exercise programs, educational support and counseling, and energy conservation strategies. A trial of a stimulant medication is also reasonable. Given the heterogeneity of patients, individualized approaches are needed. For anemic patients undergoing chemotherapy, erythropoietic agents can increase hemoglobin levels. The impact of these drugs on fatigue and quality of life is uncertain. Recent reports of increased mortality and thrombotic events in cancer patients treated with epoetin require further investigation.
authors.affiliation: Hematology/Oncology Division, Tufts-New England Medical Center, Boston, Massachusetts, USA.
authors.forename: Andrew J
authors.initials: AJ
authors.lastname: Lipman
authors.forename: Donald P
authors.initials: DP
authors.lastname: Lawrence
mesh_terms: D000928:Antidepressive Agents / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003376:Counseling; D003863:Depression / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology* / Q000628:therapy*; D003937:Diagnosis, Differential; D004334:Drug Administration Schedule; D004921:Erythropoietin / Q000627:therapeutic use; D015444:Exercise; D005221:Fatigue / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology* / Q000628:therapy*; D006801:Humans; D009369:Neoplasms / Q000150:complications* / Q000523:psychology; D010166:Palliative Care / Q000379:methods*; D016032:Randomized Controlled Trials as Topic; D012657:Self-Help Groups; D012720:Severity of Illness Index; D019452:Terminally Ill
chemical_list: D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D004921:Erythropoietin